Edgewise Therapeutics Inc

Edgewise Therapeutics Inc

EWTX

Market Cap$1.39B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Edgewise Therapeutics IncEdgewise Therapeutics Inc-8.6--34%--
$50.00

Target Price by Analysts

279.7% upsideEdgewise Therapeutics Target Price DetailsTarget Price
$0.40

Current Fair Value

97% downside

Overvalued by 97% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.39 Billion
Enterprise Value$1.35 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.45
Beta0.29
Outstanding Shares95,130,053

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-8.58
PEG-19.93
Price to Sales-
Price to Book Ratio3.29
Enterprise Value to Revenue-
Enterprise Value to EBIT-7.94
Enterprise Value to Net Income-10
Total Debt to Enterprise0.01
Debt to Equity0.03

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Edgewise Therapeutics Inc

19 employees

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need....